Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06179459 · ClinicalTrials.gov registry record

Registry of Patients Undergoing Endoscopic Management of Pancreatic Fluid Collections

A clinical trial of Acute Pancreatitis and Pancreatic Necrosis, sponsored by Orlando Health.

Recruiting
Registry status
1,000
Enrollment target
1
Study location

NCT06179459: Recruiting study of Acute Pancreatitis and Pancreatic Necrosis, sponsored by Orlando Health.

NCT06179459 is a study of Acute Pancreatitis and Pancreatic Necrosis that is actively recruiting participants, run by Orlando Health. The registered enrollment target is 1,000 participants, below the 2,219-participant average among 10 other Acute Pancreatitis trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06179459, a study of Acute Pancreatitis and Pancreatic Necrosis, is actively recruiting participants, sponsored by Orlando Health.

RECRUITING
Registry status
1,000 participants
Enrollment target
1
Study location

Study Summary

Acute pancreatitis is one of the most common gastrointestinal disorders requiring hospitalization worldwide. Pancreatic fluid collections can occur as a consequence of acute and chronic pancreatitis and can result in significant morbidity and mortality, including significant abdominal pain, gastric outlet obstruction, biliary obstruction, organ failure, persistent unwellness, infection and sepsis. Symptomatic pancreatic fluid collections require treatment, and endoscopic drainage is considered standard of care. The aim of this study is to evaluate the treatment outcomes in patients undergoing standard of care, endoscopic treatment of pancreatic fluid collections.

Primary Outcome

Treatment outcomes in patients undergoing endoscopic treatment of pancreatic fluid collections is assessed as a composite measure consisting of 1) adverse events or 2) need for hospital admission due to underlying disease or procedure-related adverse events, in patients undergoing endoscopic treatment of pancreatic fluid collections, according to timing of treatment.

Interventions

  • PROCEDURE Endoscopic management of pancreatic fluid collections

Study Locations (1)

Florida

  • Orlando Health - Orlando

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2021-05-01
Est. Completion 2032-12
Orlando Health

21 total trials

What NCT06179459 shows while recruiting

NCT06179459 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, below the 2,219-participant average among 10 other Acute Pancreatitis trials with a reported enrollment target (55% lower).

The record links to 3 conditions, with Acute Pancreatitis appearing as the primary indexed condition, and to 1 intervention - of which Endoscopic management of pancreatic fluid collections is the first listed.

NCT06179459 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT06179459 about?

NCT06179459 is a clinical study titled "Registry of Patients Undergoing Endoscopic Management of Pancreatic Fluid Collections". Acute pancreatitis is one of the most common gastrointestinal disorders requiring hospitalization worldwide. Pancreatic fluid collections can occur as a consequence of acute and chronic pancreatitis and can result in significant morbidity and mortality, including significant abdominal pain, gastric ...

What is the current status of trial NCT06179459?

This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2021-05-01. Estimated completion is 2032-12.

What conditions does trial NCT06179459 study?

This clinical trial studies the following conditions: Acute Pancreatitis, Pancreatic Necrosis, Pancreatic Pseudocyst.

What interventions are being tested in trial NCT06179459?

The interventions under investigation include: Endoscopic management of pancreatic fluid collections (PROCEDURE).

Who is sponsoring clinical trial NCT06179459?

This trial is sponsored by Orlando Health, which has 21 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06179459 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acute Pancreatitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06179459's enrollment target sits among peer trials

1,000 2nd of 10 the highest of 10 other Acute Pancreatitis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Acute Pancreatitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00018044 · 1,000 participants

    Study of Mycobacterial Infections

  • NCT01036581 · 1,000 participants · NA

    Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging

  • NCT01192048 · 1,000 participants

    Genetics of Congenital Heart Disease

  • NCT01553214 · 1,000 participants · Phase 4

    Improving White Blood Cell Collection From Healthy Donors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06179459, the US trial registry maintained by the National Library of Medicine. NCT06179459 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.